MERUS N V's ticker is MRUS and the CUSIP is N5749R100. A total of 17 filers reported holding MERUS N V in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $7,252,000 | -2.3% | 495,016 | -1.5% | 1.02% | -7.6% |
| Q1 2019 | $7,426,000 | +5.5% | 502,795 | 0.0% | 1.10% | +10.9% |
| Q4 2018 | $7,039,000 | -67.7% | 502,795 | -54.4% | 0.99% | -42.7% |
| Q3 2018 | $21,769,000 | -32.2% | 1,102,795 | -21.8% | 1.73% | -46.5% |
| Q2 2018 | $32,101,000 | +22.8% | 1,410,417 | 0.0% | 3.23% | -1.5% |
| Q1 2018 | $26,135,000 | -4.5% | 1,410,417 | 0.0% | 3.28% | -14.6% |
| Q4 2017 | $27,362,000 | -2.4% | 1,410,417 | 0.0% | 3.84% | +5.2% |
| Q3 2017 | $28,025,000 | +25.4% | 1,410,417 | 0.0% | 3.65% | +36.4% |
| Q2 2017 | $22,355,000 | -35.0% | 1,410,417 | 0.0% | 2.68% | -27.0% |
| Q1 2017 | $34,400,000 | +15.5% | 1,410,417 | 0.0% | 3.66% | +29.2% |
| Q4 2016 | $29,774,000 | +26.0% | 1,410,417 | 0.0% | 2.84% | +35.2% |
| Q3 2016 | $23,624,000 | +109.6% | 1,410,417 | 0.0% | 2.10% | +77.3% |
| Q2 2016 | $11,269,000 | – | 1,410,417 | – | 1.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd | 1,600,000 | $33,712,000 | 6.04% |
| BVF INC/IL | 7,285,071 | $153,496,000 | 5.75% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 320,815 | $6,760,000 | 3.02% |
| Burrage Capital Management LLC | 130,683 | $2,753,000 | 2.76% |
| MPM BioImpact LLC | 700,879 | $14,768,000 | 2.43% |
| Boxer Capital, LLC | 1,900,000 | $40,033,000 | 1.41% |
| Octagon Capital Advisors LP | 206,927 | $4,360,000 | 0.90% |
| DAFNA Capital Management LLC | 157,841 | $3,326,000 | 0.70% |
| Ghost Tree Capital, LLC | 75,000 | $1,580,000 | 0.43% |
| SPHERA FUNDS MANAGEMENT LTD. | 286,506 | $6,037,000 | 0.41% |